Zentalis Pharmaceuticals, Inc. (ZNTL) Stock buybacks 2023–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$10.0MFY2025 · since FY2023: $0 → $10.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.0M | — |
| FY2024 | $0 | — |
| FY2023 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZNTL financial trends
ZNTL RevenueZNTL Net incomeZNTL Net marginZNTL Gross profitZNTL Gross marginZNTL Operating incomeZNTL Operating marginZNTL Operating cash flowZNTL Free cash flowZNTL Capital expendituresZNTL Return on equityZNTL Dividends paidZNTL Total assetsZNTL Total liabilitiesZNTL Shareholders’ equityZNTL overview →